Sale of Coty 11 times greater profit guarantees to Hypermarcas for the quarter

Hypermarcas had net income attributable to partners R$ controllers 1.008 billion in the first quarter of this year, more than 11 times the R$ 90.7 million same period in 2015. The high is mainly due to the result of the sale of the cosmetics business, Coty, in February, according to statements of quarterly results released by the company late on Tuesday. The net revenue of the company, owner of the medicines ASA Coristina D, Atroveran, pain killer, among others, totaled R$ 827.3 million, up 12.1% on R$ 737.7 million in the first quarter of 2015. Ebitda-earnings before interest, taxes, depreciation and amortization-continuing operations totaled R$ 310.3 million, with margin of 37.5% in the first quarter of this year, 11.2% above the value R$ 279.1 million in the same quarter of 2015.